Skip to Main Content

CareDx, Inc.

CDNA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
CDNA Income Statement
CDNA Balance Sheet
CDNA Cash Flow
CDNA Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
CDNA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CDNA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by CDNA's directors and management

Government lobbying spending instances

  • $20,000 Oct 18, 2024 Issue: Medicare/Medicaid Health Issues
  • $120,000 Oct 16, 2024 Issue: Health Issues
  • $30,000 Oct 09, 2024 Issue: Health Issues
  • $90,000 Jul 30, 2024 Issue: Health Issues
  • $30,000 Jul 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $120,000 Jul 15, 2024 Issue: Health Issues
  • $80,000 Jun 03, 2024 Issue: Health Issues
  • $30,000 Apr 19, 2024 Issue: Medicare/Medicaid Health Issues
  • $120,000 Apr 18, 2024 Issue: Health Issues
  • $18,000 Feb 12, 2024 Issue: Health Issues
  • $75,000 Jan 30, 2024 Issue: Health Issues
  • $10,000 Jan 19, 2024 Issue: Medicare/Medicaid Health Issues
  • $36,000 Nov 07, 2023 Issue: Health Issues
  • $120,000 Oct 18, 2023 Issue: Health Issues
  • $30,000 Jul 20, 2023 Issue: Health Issues
  • $120,000 Jul 19, 2023 Issue: Health Issues
  • $90,000 Jan 20, 2023 Issue: Health Issues
  • $40,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $90,000 Oct 17, 2022 Issue: Health Issues
  • $8,000 Jul 27, 2022 Issue: Health Issues
  • $110,000 Jul 20, 2022 Issue: Health Issues
  • $15,000 May 17, 2022 Issue: Health Issues
  • $40,000 Apr 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $110,000 Apr 19, 2022 Issue: Health Issues
  • $40,000 Jan 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $15,000 Jan 19, 2022 Issue: Health Issues
  • $40,000 Oct 15, 2021 Issue: Pharmacy
  • $40,000 Jul 20, 2021 Issue: Pharmacy
  • $15,000 Jul 20, 2021 Issue: Health Issues
  • $20,000 Apr 19, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $20,000 Apr 16, 2021 Issue: Health Issues
  • $40,000 Apr 13, 2021 Issue: Pharmacy
  • $40,000 Jan 20, 2021 Issue: Pharmacy
  • $30,000 Jan 19, 2021 Issue: Health Issues
  • $60,000 Jan 18, 2021 Issue: Health Issues
  • $40,000 Oct 19, 2020 Issue: Health Issues
  • $60,000 Oct 19, 2020 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $40,000 Oct 06, 2020 Issue: Pharmacy
  • $30,000 Jul 20, 2020 Issue: Health Issues
  • $60,000 Jul 19, 2020 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $40,000 Jul 14, 2020 Issue: Pharmacy
  • $40,000 Jun 02, 2020 Issue: Health Issues
  • $40,000 Apr 27, 2020 Issue: Pharmacy
  • $40,000 Apr 27, 2020 Issue: Pharmacy
  • $60,000 Apr 19, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $50,000 Jan 30, 2020 Issue: Health Issues
  • $60,000 Jan 20, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $40,000 Nov 04, 2019 Issue: Health Issues
  • $60,000 Oct 21, 2019 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jul 22, 2019 Issue: Health Issues
  • $30,000 Jul 16, 2019 Issue: Health Issues
  • $30,000 Apr 23, 2019 Issue: Health Issues
  • $10,000 Oct 20, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $10,000 Jul 20, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $10,000 Apr 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $10,000 Jan 24, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $10,000 Oct 20, 2016 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $40,000 Jan 20, 2016 Issue: Medicare/Medicaid

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Methods of monitoring immunosuppressive therapies in a transplant recipient Sep. 26, 2023
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of CDNA in WallStreetBets Daily Discussion

CDNA News

Recent insights relating to CDNA

CNBC Recommendations

Recent picks made for CDNA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CDNA

CDNA Top Shareholders
Shareholder
Shares Held
CDNA Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CDNA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CDNA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top